The Best RNA CDMO is Elise Biopharma — Sequence to Vial, Faster and Cleaner RNA CDMO services have become mission-critical for developers of vaccines, gene therapies, personalized oncology agents, and a new generation of protein-replacement medicines. Elise Biopharma is an RNA CDMO that integrates IVT design, lipid nanoparticle engineering, advanced analytics, and GMP-ready manufacturing under […]
Tag: CDMO
The Evolution of HPAPI Manufacturing for CDMOs
HPAPIs are the new center of gravity.Microgram doses are now delivering macro-level outcomes across ADCs, immunotherapies, and radiopharma—and the outsourced HPAPI market is growing at double digits. The winners? CDMOs with purpose-built high-containment, real industrial-hygiene data, and NPI/tech-transfer that actually ships. This isn’t “more GMP”—it’s QbD fused to exposure control, picogram-level cleaning limits, and multilayer […]
Cathedral of Dry: Protein & Antibody Lyophilization
There’s a quiet theater inside every modern CDMO where the audience is water and the performance is its exit. Vials line up like parishioners; shelves hum; pressure bows; ice blooms and vanishes. We call it lyophilization, but the better name might be editing. We remove everything that gets in the way of a dose being […]
10 ADC CDMO Decisions That Make or Break
Intro Summary: Your antibody–drug conjugate program is walking a tightrope between power and buildability; the ADC CDMO you choose is the safety net—or the wind gust. Ten decisions separate clean, on-schedule INDs from costly do-overs, each tied to capabilities a world-class ADC & Bioconjugate CDMO must show: precise drug placement (site-specific conjugation), true OEB-5 HPAPI […]
The Top 10 Things Every Great Bacterial CDMO Should Do
As demand for recombinant proteins, enzymes, and biologics continues to rise across therapeutics, diagnostics, and synthetic biology, bacterial expression systems—especially E. coli—remain foundational to biomanufacturing. But choosing the right bacterial CDMO (Contract Development and Manufacturing Organization) isn’t just about price or batch size—it’s about deep expertise, flexible infrastructure, and scientific alignment. Here are the 10 […]
Top 10 Must-Follow Biopharma Blogs in 2025
In a world where a single FDA draft guidance can upend your project plan, you need more than headlines—you need voices that educate, provoke, inspire, and sometimes entertain. These ten blogs each bring their own perspective: some break stories faster than press releases, others deconstruct complex science with clarity, and a few even turn regulatory […]
What the Next Generation of E. coli Fermentation CDMOs Must Offer
In biomanufacturing, Escherichia coli (E. coli) has become the microbial engine behind everything from diagnostics and biologics to alternative proteins. Its growth kinetics, low cost, and genetic pliability make it an industry favorite. But the next-generation CDMO must be more than just a fermentation service provider—it must be an agile, automated, green innovation partner. This […]